BioMarin Pharma (BMRN) Receives CRL from FDA for Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. MU
5. GOOGL
6. APGE
7. DFTX
8. LCO
9. KR
10. MSTR

Go back to BioMarin Pharma (BMRN) Receives CRL from FDA for Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 55.60 +0.91 (1.66%)
Previous Close $54.69    52 Week High $108.96 
Open $55.51    52 Week Low $62.12 
Day High $55.87    P/E N/A 
Day Low $54.96    EPS $-1.27 
Volume 739,679